BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15891564)

  • 21. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
    Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
    Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH; Srivastav A; Lindley MC; Fisher A; Kim D; Greby SM; Lee J; Singleton JA
    Am J Prev Med; 2022 Mar; 62(3):367-376. PubMed ID: 35190101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.
    Groves FD; Gridley G; Wacholder S; Shu XO; Robison LL; Neglia JP; Linet MS
    Br J Cancer; 1999 Sep; 81(1):175-8. PubMed ID: 10487630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
    Loeb M; Russell ML; Neupane B; Thanabalan V; Singh P; Newton J; Pullenayegum E
    Vaccine; 2018 Nov; 36(48):7423-7429. PubMed ID: 30352746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.
    Boulianne N; De Serres G; Ratnam S; Ward BJ; Joly JR; Duval B
    Vaccine; 1995 Nov; 13(16):1611-6. PubMed ID: 8578850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age.
    Dagan R; Igbaria K; Piglansky L; Van Brusteghem F; Melot V; Kaufhold A
    Vaccine; 1999 Jun; 17(20-21):2620-7. PubMed ID: 10418911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.
    Mansor-Lefebvre S; Le Strat Y; Bernadou A; Vignier N; Guthmann JP; Arnaud A; Lévy-Bruhl D; Vandentorren S
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326203
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
    Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
    J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
    Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
    Postgrad Med; 1989 Feb; 85(2):183-6, 188-90, 195-8. PubMed ID: 2783777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four- to six-year-olds.
    Pichichero ME; Anderson EL; Rennels MB; Edwards KM; England JA
    Pediatr Infect Dis J; 2001 Apr; 20(4):427-33. PubMed ID: 11332669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
    Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
    Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination.
    Cox M; Adetifa JU; Noho-Konteh F; Njie-Jobe J; Sanyang LC; Drammeh A; Plebanski M; Whittle HC; Rowland-Jones SL; Robertson I; Flanagan KL
    Front Immunol; 2020; 11():1083. PubMed ID: 32582177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
    Simoes EA; Balraj V; Selvakumar R; John TJ
    Am J Dis Child; 1988 Mar; 142(3):309-11. PubMed ID: 3257842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.